(Q40142846)

17 September 2017

title

Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis (English)

1 reference

17 September 2017

1 reference

Yue-Wei Qian

1

1 reference

17 September 2017

Robert J Schmidt

2

1 reference

17 September 2017

Youyan Zhang

3

1 reference

17 September 2017

Shaoyou Chu

4

1 reference

17 September 2017

Aimin Lin

5

1 reference

17 September 2017

He Wang

6

1 reference

17 September 2017

Xiliang Wang

7

1 reference

17 September 2017

Thomas P Beyer

8

1 reference

17 September 2017

William R Bensch

9

1 reference

17 September 2017

Weiming Li

10

1 reference

17 September 2017

Mariam E Ehsani

11

1 reference

17 September 2017

Deshun Lu

12

1 reference

17 September 2017

Robert J Konrad

13

1 reference

17 September 2017

Patrick I Eacho

14

1 reference

17 September 2017

David E Moller

15

1 reference

17 September 2017

Sotirios K Karathanasis

16

1 reference

17 September 2017

Guoqing Cao

17

1 reference

17 September 2017

publication date

20 April 2007

1 reference

Journal of Lipid Research

17 September 2017

published in

1 reference

17 September 2017

volume

48

1 reference

17 September 2017

issue

7

1 reference

17 September 2017

page(s)

1488-1498

1 reference

The IDEAL cholesterol: lower is better

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Effect of mutations in the PCSK9 gene on the cell surface LDL receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M700071-JLR200

10.1194/JLR.M700071-JLR200

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference